Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06361537 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 124 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | October 3, 2025 (Oct 3, 2025) |
As of March 2, 2026: Clinical trial NCT06361537 is currently recruiting participants. This clinical trial study for hereditary angioedema is actively seeking new participants at 3 locations across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06361537 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06361537 was last updated Oct 3, 2025 (October 3, 2025). HelloStudys verifies this status automatically.